pharmaceutical roundtable

These grants are open to applicants from any country. 

The ACS GCI Pharmaceutical Roundtable identifies key research areas representing the pharmaceutical industry’s perspective on where advances in understanding would be most likely to yield more sustainable chemistries and processes of interest to pharma and allied industries. From these areas, the GCIPR selects a handful each year for Key Research Area Grants—currently a $80,000 award for a 12-month research commitment. Grant winners work closely with the GCIPR focus team that proposed the grant topic.

These grants are open to applicants from any country. 

The Ignition Grant program launched in 2016 to support high-risk, high-reward projects that aims to accelerate progress in green chemistry technologies by incentivizing innovation.  Ignition grants currently provide recipients with $40,000 over six months. Award winners work closely with appropriate GCIPR members depending on the topic.

Four Ignition Grants will be awarded in 2025.

Purpose: To recognize outstanding efforts in discovery chemistry that demonstrate compelling environmental, safety and/or efficiency improvements through green chemistry and engineering.

Nominations are due December 1, 2024 at 11:59 EST (GMT-5).

The Peter J. Dunn Awards were established in 2016 by the ACS GCI Pharmaceutical Roundtable (ACS GCIPR) to recognize excellence in the research, development and execution of green chemistry that demonstrates compelling environmental, safety and efficiency improvements over current technologies in the pharmaceutical industry and its allied industrial partners. The inaugural award was given to Peter J. Dunn of Pfizer, and the award was subsequently named in his honor.